Basic Information
RNALocate ID: RLID:01001784
RNA Symbol: hsa-miR-141-3p
Localization: P-body
RNA Information
RNA Name: hsa-miR-141
RNA ID: miRBase:MIMAT0000432
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 28488892
Tissue/Cell Line: HeLa cells
Method: IFA
Condition: Overexpression of Dcp1a, GW182, and G3BP1
Description: To further confirm that Cy3-miRNA-141 can also be recruited into endo-P-bodies, we analyzed the P-bodies using a specific antibody for Dcp1a and found that miRNA was localized in the endo-P-bodies soon after being transfected into the cells (Fig. 3C).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001783 Nucleus Colon adenocarcinoma cells 20864815
RLID:11001768 Exosome Human milk 28688106
RLID:11001769 Exosome Pulmonary epithelial cell line (BEAS-2B) 31520698
RLID:11001770 Exosome Breast cancer cell line (MCF-7) 20976003
RLID:11001771 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11001772 Exosome Renal cancer cells 21670082
RLID:11001773 Exosome Brain tissue 23382797
RLID:11001774 Exosome Plasma 23663360
RLID:11001775 Microvesicle Seminal plasma 23539611
RLID:21000268 Cytoplasmic stress granule HeLa cells 28488892
RLID-D:11000082 Exosome Breast milk|Colon tissue|Seminal fluid
RLID-D:11000360 Microvesicle Colon cancer cell line (LIM1863)|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-141-3p Splenic marginal zone lymphoma MNDR-E-MI-13652
MNDR hsa-miR-141-3p Renal fibrosis MNDR-E-MI-13653
MNDR hsa-miR-141-3p Oral squamous cell carcinoma MNDR-E-MI-13654
MNDR hsa-miR-141-3p Large cell neuroendocrine cancer MNDR-E-MI-13655
MNDR hsa-miR-141-3p High-grade serous ovarian carcinoma MNDR-E-MI-13656
MNDR hsa-miR-141-3p Ovarian clear cell carcinoma MNDR-E-MI-13657
MNDR hsa-miR-141-3p Uterine corpus endometrial carcinoma MNDR-E-MI-13658
MNDR hsa-miR-141-3p Lymphoma MNDR-E-MI-13659
MNDR hsa-miR-141-3p Lymphoma non-hodgkin MNDR-E-MI-13660
MNDR hsa-miR-141-3p Estrogen-receptor positive breast cancer MNDR-E-MI-13661
MNDR hsa-miR-141-3p Estrogen-receptor negative breast cancer MNDR-E-MI-13662
MNDR hsa-miR-141-3p Progesterone-receptor positive breast cancer MNDR-E-MI-13663
MNDR hsa-miR-141-3p Progesterone-receptor negative breast cancer MNDR-E-MI-13664
MNDR hsa-miR-141-3p Her2-receptor positive breast cancer MNDR-E-MI-13665
MNDR hsa-miR-141-3p Breast cancer luminal MNDR-E-MI-13666
MNDR hsa-miR-141-3p Dermatomyositis MNDR-E-MI-13667
MNDR hsa-miR-141-3p Prostate cancer MNDR-E-MI-13668
MNDR hsa-miR-141-3p Gastric cancer MNDR-E-MI-13669
MNDR hsa-miR-141-3p Gastric lymphoma MNDR-E-MI-13670
MNDR hsa-miR-141-3p Alzheimer disease MNDR-E-MI-13671
MNDR hsa-miR-141-3p Sickle cell anemia MNDR-E-MI-13672
MNDR hsa-miR-141-3p Bladder cancer MNDR-E-MI-13673
MNDR hsa-miR-141-3p Esophageal carcinoma MNDR-E-MI-13674
MNDR hsa-miR-141-3p Dysautonomia familial MNDR-E-MI-13675
MNDR hsa-miR-141-3p Head and neck cancer MNDR-E-MI-13676
MNDR hsa-miR-141-3p Huntington disease MNDR-E-MI-13677
MNDR hsa-miR-141-3p Chorea MNDR-E-MI-13678
MNDR hsa-miR-141-3p Cardiovascular disease MNDR-E-MI-13679
MNDR hsa-miR-141-3p Lung cancer MNDR-E-MI-13680
MNDR hsa-miR-141-3p Endometrial cancer MNDR-E-MI-13681
MNDR hsa-miR-141-3p Parkinson disease MNDR-E-MI-13682
MNDR hsa-miR-141-3p Breast cancer MNDR-E-MI-13683
MNDR hsa-miR-141-3p Cancer MNDR-E-MI-13684
MNDR hsa-miR-141-3p Thyroid cancer MNDR-E-MI-13685
MNDR hsa-miR-141-3p Pituitary neoplasms MNDR-E-MI-13686
MNDR hsa-miR-141-3p Pancreatic cancer MNDR-E-MI-13687
MNDR hsa-miR-141-3p Melanoma MNDR-E-MI-13688
MNDR hsa-miR-141-3p Rectum adenocarcinoma MNDR-E-MI-13689
MNDR hsa-miR-141-3p Nephroblastoma MNDR-E-MI-13690
MNDR hsa-miR-141-3p Colon cancer MNDR-E-MI-13691
MNDR hsa-miR-141-3p Ischemic attack transient MNDR-E-MI-13692
MNDR hsa-miR-141-3p Colon adenocarcinoma MNDR-E-MI-13693
MNDR hsa-miR-141-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-13694
MNDR hsa-miR-141-3p Familial ovarian cancer MNDR-E-MI-13695
MNDR hsa-miR-141-3p Prostate adenocarcinoma MNDR-E-MI-13696
MNDR hsa-miR-141-3p Kidney neoplasms MNDR-E-MI-13697
MNDR hsa-miR-141-3p Endometrial endometrioid carcinoma MNDR-E-MI-13698
MNDR hsa-miR-141-3p Carcinoma ductal breast MNDR-E-MI-13699
MNDR hsa-miR-141-3p Glioblastoma MNDR-E-MI-13700
MNDR hsa-miR-141-3p Glioma MNDR-E-MI-13701
MNDR hsa-miR-141-3p Chronic obstructive pulmonary disease MNDR-E-MI-13702
MNDR hsa-miR-141-3p Amyotrophic lateral sclerosis MNDR-E-MI-13703
MNDR hsa-miR-141-3p Epilepsy temporal lobe MNDR-E-MI-13704
MNDR hsa-miR-141-3p Osteosarcoma MNDR-E-MI-13705
MNDR hsa-miR-141-3p Liposarcoma MNDR-E-MI-13706
MNDR hsa-miR-141-3p Breast carcinoma MNDR-E-MI-13707
MNDR hsa-miR-141-3p Liver neoplasms MNDR-E-MI-13708
MNDR hsa-miR-141-3p Choriocarcinoma MNDR-E-MI-13709
MNDR hsa-miR-141-3p Uterine cancer MNDR-E-MI-13710
MNDR hsa-miR-141-3p Cervical adenocarcinoma MNDR-E-MI-13711
MNDR hsa-miR-141-3p Gastric adenocarcinoma MNDR-E-MI-13712
MNDR hsa-miR-141-3p Cervical squamous cell carcinoma MNDR-E-MI-13713
MNDR hsa-miR-141-3p Pituitary adenoma MNDR-E-MI-13714
MNDR hsa-miR-141-3p Lung squamous cell carcinoma MNDR-E-MI-13715
MNDR hsa-miR-141-3p Non-small cell lung adenocarcinoma MNDR-E-MI-13716
MNDR hsa-miR-141-3p Lung adenocarcinoma MNDR-E-MI-13717
MNDR hsa-miR-141-3p Adrenocortical carcinoma MNDR-E-MI-13718
MNDR hsa-miR-141-3p Thyroid carcinoma MNDR-E-MI-13719
MNDR hsa-miR-141-3p Ovarian carcinoma MNDR-E-MI-13720
MNDR hsa-miR-141-3p Bladder urothelial carcinoma MNDR-E-MI-13721
MNDR hsa-miR-141-3p Carcinoma renal cell MNDR-E-MI-13722
MNDR hsa-miR-141-3p Kidney renal papillary cell carcinoma MNDR-E-MI-13723
MNDR hsa-miR-141-3p Clear cell renal cell carcinoma MNDR-E-MI-13724
MNDR hsa-miR-141-3p Biliary tract cancer MNDR-E-MI-13725
MNDR hsa-miR-141-3p Intrahepatic cholangiocarcinoma MNDR-E-MI-13726
MNDR hsa-miR-141-3p Cholangiocarcinoma MNDR-E-MI-13727
MNDR hsa-miR-141-3p Lung small cell carcinoma MNDR-E-MI-13728
MNDR hsa-miR-141-3p Head and neck squamous cell carcinoma MNDR-E-MI-13729
MNDR hsa-miR-141-3p Growth hormone-secreting pituitary adenoma MNDR-E-MI-13730
MNDR hsa-miR-141-3p Breast invasive carcinoma MNDR-E-MI-13731
MNDR hsa-miR-141-3p Hepatocellular carcinoma MNDR-E-MI-13732
MNDR hsa-miR-141-3p Familiar ovarian carcinoma MNDR-E-MI-13733
MNDR hsa-miR-141-3p B-cell lymphoma MNDR-E-MI-13734
MNDR hsa-miR-141-3p Rheumatoid arthritis MNDR-E-MI-13735
MNDR hsa-miR-141-3p Ulcerative colitis MNDR-E-MI-13736
MNDR hsa-miR-141-3p Burkitt lymphoma MNDR-E-MI-13737
MNDR hsa-miR-141-3p Crohn disease MNDR-E-MI-13738
MNDR hsa-miR-141-3p Psoriasis MNDR-E-MI-13739
MNDR hsa-miR-141-3p Skin cutaneous melanoma MNDR-E-MI-13740
MNDR hsa-miR-141-3p Skin melanoma MNDR-E-MI-13741
MNDR hsa-miR-141-3p Acute myelogenous leukemia MNDR-E-MI-13742
MNDR hsa-miR-141-3p Colorectal cancer MNDR-E-MI-13743
MNDR hsa-miR-141-3p Nasopharyngeal carcinoma MNDR-E-MI-13744
MNDR hsa-miR-141-3p Nasopharynx carcinoma MNDR-E-MI-13745
MNDR hsa-miR-141-3p Multiple myeloma MNDR-E-MI-13746
MNDR hsa-miR-141-3p Ovarian epithelial cancer MNDR-E-MI-13747
MNDR hsa-miR-141-3p Esophageal squamous cell carcinoma MNDR-E-MI-13748
MNDR hsa-miR-141-3p Uterine cervical neoplasms MNDR-E-MI-13749
MNDR hsa-miR-141-3p Ependymoma MNDR-E-MI-13750
MNDR hsa-miR-141-3p Nasopharyngeal cancer MNDR-E-MI-13751
MNDR hsa-miR-141-3p Prostatic neoplasms MNDR-E-MI-13752
MNDR hsa-miR-141-3p Epstein-barr virus infections MNDR-E-MI-13753
MNDR hsa-miR-141-3p Brain injury chronic MNDR-E-MI-13754
MNDR hsa-miR-141-3p Intracranial hemorrhage hypertensive MNDR-E-MI-13755
MNDR hsa-miR-141-3p Pituitary acth hypersecretion MNDR-E-MI-13756
MNDR hsa-miR-141-3p Breast cancer her3+ negative MNDR-E-MI-13757
MNDR hsa-miR-141-3p Low grade dysplastic nodule MNDR-E-MI-13758
MNDR hsa-miR-141-3p Renal childhood neoplasms MNDR-E-MI-13759
MNDR hsa-miR-141-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-13760
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ACVR2B Homo sapiens RR00039524
TOP